Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001275903 | SCV001633160 | likely benign | Tay-Sachs disease | 2025-01-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002336796 | SCV002644134 | likely benign | Inborn genetic diseases | 2022-08-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV001275903 | SCV002799881 | likely benign | Tay-Sachs disease | 2021-09-08 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001275903 | SCV001461556 | likely benign | Tay-Sachs disease | 2020-09-16 | no assertion criteria provided | clinical testing |